Transaction overview
CONX Corp, a US-based special purpose acquisition company (SPAC) listed on NASDAQ, acquired a majority stake of 68% in Red Technologies, a French technology firm specializing in radio spectrum management and sharing solutions, for €18.6 million ($20 million USD). The deal was announced on December 11, 2024, with the transaction closing on December 5, 2024. Founded in Paris in 2012, Red Technologies provides cloud-based spectrum-sharing technologies and services aimed at operators in both American and European markets.
Deal structure and financing
The acquisition by CONX Corp did not disclose specific details regarding its equity and debt composition or the involvement of financial institutions beyond Karista as the sell-side advisor. However, given the deal value and typical SPAC practices, it is likely that a significant portion was funded through existing cash reserves of CONX Corp on NASDAQ. No retained stake by Red Technologies' management or seller lock-up terms were mentioned in public disclosures, and no immediate plans for an IPO following this transaction have been announced.
Strategic context
CONX Corp's acquisition of Red Technologies is driven by the latter’s innovative radio spectrum sharing technology, which has gained recognition from key regulatory bodies such as the Federal Communications Commission (FCC) in the United States. This strategic move positions CONX Corp to leverage Red Technologies’ expertise and patented solutions, particularly in emerging markets like Citizens Broadband Radio Service (CBRS). For Karista, this transaction represents a successful exit after nine years of investment, underscoring their ability to nurture high-potential European DeepTech companies.
Regulatory path
The acquisition required review by the relevant regulatory bodies within France and the United States. Given that Red Technologies operates in both the American and European markets with significant technological applications, particularly in military dual-use technology, it is likely that antitrust authorities such as the Federal Trade Commission (FTC) or Department of Justice (DOJ) in the US and the Autorité de la Concurrence in France scrutinized the deal. No specific remedies were mentioned as part of the transaction terms, indicating a relatively straightforward approval process without significant regulatory hurdles.